SMTL ID : 6cyu.1

Crystal structure of CTX-M-14 S70G/N106S/D240G beta-lactamase in complex with hydrolyzed cefotaxime

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.82 Å

Oligo State

monomer

Ligands

1 x CE4: (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro -2H-1,3-thiazine-4-carboxylic acid(Non-covalent)

CE4.1: 15 residues within 4Å: Chain A: C.44, G.45, K.48, Y.80, S.105, N.107, E.141, P.142, N.145, K.209, T.210, G.211, S.212, G.213, G.214 14 PLIP interactions: 14 interactions with chain A Hydrogen bonds: A:G.45, A:S.105, A:N.107, A:T.210, A:S.212, A:S.212, A:S.212, A:S.212, A:G.214 Water bridges: A:N.145, A:K.209 Salt bridges: A:K.48, A:K.209, A:K.209

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Patel, M.P. et al., Synergistic effects of functionally distinct substitutions in beta-lactamase variants shed light on the evolution of bacterial drug resistance. J. Biol. Chem. (2018)

Release Date

2018-10-10

Peptides

Beta-lactamase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-lactamase